A novel Keap1-Nrf2 inhibitor 6K delays the progression of AKI-to-CKD by mitigating maladaptive repair.
- DOI
- 10.1016/j.redox.2026.104374
- Published
- 2026 Sep 2
- Container
- Redox biology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.redox.2026.104374,
title = {A novel Keap1-Nrf2 inhibitor 6K delays the progression of AKI-to-CKD by mitigating maladaptive repair.},
author = {Wang Y and Sun Y and Zhou T and Gao C and Liu J and Chen Z and Qiao P and Shao G and Li M and Yang B and Zhuang C and Zhou H},
year = {2026},
journal = {Redox biology},
doi = {10.1016/j.redox.2026.104374},
url = {https://doi.org/10.1016/j.redox.2026.104374}
}RIS
TY - JOUR TI - A novel Keap1-Nrf2 inhibitor 6K delays the progression of AKI-to-CKD by mitigating maladaptive repair. AU - Wang Y AU - Sun Y AU - Zhou T AU - Gao C AU - Liu J AU - Chen Z AU - Qiao P AU - Shao G AU - Li M AU - Yang B AU - Zhuang C AU - Zhou H PY - 2026 JO - Redox biology DO - 10.1016/j.redox.2026.104374 UR - https://doi.org/10.1016/j.redox.2026.104374 ER -
APA
Y, W., Y, S., T, Z., C, G., J, L., Z, C., P, Q., G, S., M, L., B, Y., C, Z., & H, Z. (2026). A novel Keap1-Nrf2 inhibitor 6K delays the progression of AKI-to-CKD by mitigating maladaptive repair.. Redox biology. https://doi.org/10.1016/j.redox.2026.104374
Source records
- pubmed · retrieved 2026-09-27T14:02:29.418Z